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Abstract
Background: For most people, home is the preferred place of care and death. Despite the development of
specialist palliative care and primary care models of community based service delivery, people who are dying,
and their families/carers, can experience isolation, feel excluded from social circles and distanced from their
communities. Loneliness and social isolation can have a detrimental impact on both health and quality of life.
Internationally, models of social and practical support at the end of life are gaining momentum as a result of
the Compassionate Communities movement. These models have not yet been subjected to rigorous evaluation. The
aims of the study described in this protocol are: (1) to evaluate the feasibility, acceptability and potential effectiveness
of The Good Neighbour Partnership (GNP), a new volunteer-led model of social and practical care/support for
community dwelling adults in Ireland who are living with advanced life-limiting illness; and (2) to pilot the
method for a Phase III Randomised Controlled Trial (RCT).
Design: The INSPIRE study will be conducted within the Medical Research Council (MRC) Framework for the
Evaluation of Complex Interventions (Phases 0–2) and includes an exploratory two-arm delayed intervention
randomised controlled trial. Eighty patients and/or their carers will be randomly allocated to one of two
groups: (I) Intervention: GNP in addition to standard care or (II) Control: Standard Care. Recipients of the GNP
will be asked for their views on participating in both the study and the intervention. Quantitative and qualitative data
will be gathered from both groups over eight weeks through face-to-face interviews which will be conducted before,
during and after the intervention. The primary outcome is the effect of the intervention on social and practical need.
Secondary outcomes are quality of life, loneliness, social support, social capital, unscheduled health service utilisation,
caregiver burden, adverse impacts, and satisfaction with intervention. Volunteers engaged in the GNP will also be
assessed in terms of their death anxiety, death self efficacy, self-reported knowledge and confidence with eleven skills
considered necessary to be effective GNP volunteers.
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Discussion: The INSPIRE study addresses an important knowledge gap, providing evidence on the efficacy, utility and
acceptability of a unique model of social and practical support for people living at home, with advanced life-limiting
illness. The findings will be important in informing the development (and evaluation) of similar service models and
policy elsewhere both nationally and internationally.
Trial registration: ISRCTN18400594 18th February 2015.
Keywords: Randomised Controlled Trial, Palliative care needs, Practical support, Social support, Volunteers, Community,
Adults, Carers, Quality of life, INSPIRE, Home
Background
Most people want to be cared for and to die at home [1]
and in most developed countries, this choice is sup-
ported by public policy. For example, in Ireland national
policy has, for more than 50 years, focused on trying to
ensure that older people are enabled to live in their own
homes or to ‘age in place’ for as long as possible, with
the help of both formal and informal services [2]. How-
ever, despite the development of specialist palliative care
hospice at home services and models of primary care,
people who are dying, and their families, can experience
great isolation and can feel excluded from social circles
and distanced from their communities [3]. A recent re-
view published by the Social Care Institute for Excellence
[4] highlights the detrimental impact of such loneliness
and social isolation on health and wellbeing, and, arguably
this may impact most on the quality of life of people with
palliative care needs and their families [5]. Social isolation
can also pose a barrier to the successful execution of in-
strumental activities of daily living. For example a study
by Macmillan in the United Kingdom (UK) reports that
more than 1 in 6 (18 %) people living with cancer were
unable to collect a prescription for their medication,
whilst this proportion increased to 1 in 4 (24 %) amongst
women [6]. This is only one example of the many small
practical, but significant needs of those who find them-
selves socially isolated due to end stage illness.
Existing evidence suggests that informal support net-
works may help to naturalise’ dying; offer better support
to the person and family; reduce isolation; target profes-
sional support more effectively and equitably; and enable
choice to die at home [7]. Such networks are at the
heart of Health Promoting Palliative Care theory [8],
one component of which, encourages communities to
care for people and their families as they encouter
death and in turn build Compassionate Communities
[9]. These may be described as communities that rec-
ognise “care for one another at times of health crisis,
and personal loss is not simply a task solely for health
and social services, but is everyone’s responsibility” [10].
Such community-led interventions focus on the devel-
opment and delivery of a social/professional model of care
and support for people living at home with palliative/end
of life care needs and are usually provided and/or led by
the community. Thus, they tend to involve the use of vol-
unteers and/or naturally occurring personal/informal net-
works [11, 12, 13]. The idea underpinning these models is
that, by drawing on the resources of the community, it is
possible, not only to meet a person’s social and/or prac-
tical needs, but also more broadly to build capacity and re-
silience in the community and naturalise the process of
care, dying, death and bereavement.
Community-led interventions for people with palliative
care needs and their carers have been implemented in
several countries internationally and initial positive find-
ings/outcomes reported [11]. For example, in the UK,
Severn Hospice has developed a Compassionate Com-
munities (Co-Co) befriending model where volunteers
provide practical help to people facing the end of life
with day-to-day activities such as shopping, gardening
and the collection of prescribed medication. The avail-
able evidence suggests that this model has reduced pa-
tient isolation and led to fewer unscheduled healthcare
visits to primary care and other allied health services,
thereby reducing demand on health service staff and
budgets [12].
In India, the Neighbourhood Network in Palliative
Care (NNPC) involves the community in providing
social, spiritual and emotional support to people at
home, facing the end of life, supporting more than
2500 patients per week [13–15]. In Australia, the Home
Hospice Volunteer Mentoring Model (now known as
LifeCircle) works alongside medical and other essential
home based services providing support for carers, helping
them to gather a support team and avoid burn-out. In
Spain, the SAIATU project enables the provision of
home-based social support services to complement pallia-
tive clinical services, and to enhance the care provided to
individuals living with advanced illness and their families.
An evaluation showed that those who had received this
intervention had fewer unscheduled health service visits
(Accident and Emergency, Out Patient Department and
hospital admission) when compared to the control
group. In addition, both patients and families rated
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the intervention positively, whilst the cost effective-
ness of the model was also demonstrated [16, 17].
Internationally, there is a growing policy impetus to-
ward the increased provision of community-led inter-
ventions as described above. However, the development
of models of social and practical care and support as de-
scribed above is relatively new, and robust study designs
are necessary to determine whether models of social and
practical care and support are effective. Conducting ran-
domised controlled trials with people facing the end of
life can be both ethically and methodologically challen-
ging and therefore it is important to progress methodic-
ally through the phases of Medical Research Council
(MRC) Framework for Complex Interventions [18, 19],
examining both the acceptability and feasibility of the
intervention and the associated study design [20].
Aim and objectives
The overall aims of the INSPIRE study are to (1) develop
a greater understanding of the practical and social needs
of people living with advanced life limiting illness and (2)
assess the feasibility, acceptability and subsequent effect-
iveness of The Good Neighbour Partnership (GNP), a
volunteer-led model of social and practical care/support
for community dwelling adults living with advanced life-
limiting illness in Limerick, Ireland.
These aims will be achieved by working through
the first three phases of the the MRC Framework for
the Evaluation of Complex Interventons [18, 19]. Within
Phase II of the Framework a pilot delayed intervention
randomised controlled trial will be conducted to assess
both the effectiveness of the GNP and associated research
methods, in advance of scaling up to a larger Phase III
RCT.
The specific objectives of the delayed intervention ran-
domised controlled trial are to determine whether the
GNP can:
(1)Reduce unmet social and practical need;
(2)Reduce unplanned health service utilisation;
(3)Improve overall quality of life;
(4)Reduce loneliness;
(5)Increase social capital;
(6)Improve social support;
(7)Alleviate caregiver burden.
The research team will also seek to:
(a)Develop, implement and evaluate a brief training
programme delivered to Compassionate Communities
Volunteers prior to the implementation of the GNP;
(b)Assess the impact of participation on volunteers’
death anxiety, death self-efficacy and self-reported
knowledge and confidence regarding eleven skills
considered important for volunteers to successfully
deliver the intervention; and
(c)Conduct a process evaluation, examining the
feasibility and acceptability of both the model of
care and method of evaluation from all perspectives
(patient, carer, health professional and volunteer).
Methods
Participants and settings
The care of community dwelling adults with advanced
life-limiting illness in Limerick is organised in line with
the person’s needs, through the relevant Health Service
Executive (HSE) Primary Care Team and where neces-
sary via Milford Care Centre, a Specialist Palliative Care
provider. Limerick City and County have a combined
population of 191,809, half of whom (95,894) live in
Limerick City [21]. Whilst there are significant clusters
of the population residing around large towns, there are
a large number of people living in isolated rural loca-
tions. It is anticipated that there will be a 25:75 % urban/
rural mix in this study, based on an analysis of death no-
tice data comprising 1650 deaths in the last 12 months.
Design
The evaluation will be guided by the MRC Framework
for the Evaluation of Complex Interventions [18, 19]. In
the INSPIRE study, the first three phases of the Frame-
work will be completed (i.e., from pre-clinical phases to
phase II – an exploratory trial) as outlined below and in
Figs. 1 and 2.
Phase 0 (pre-clinical) – Theory: Explore relevant theory
and evidence to ensure the best choice of intervention
and predict cofounders
A significant body of work has already been completed
by KMcL and JR to design the Good Neighbour Partner-
ship intervention. The study has been under discussion
and development for over two years. Much of this work
is undocumented and therefore this study will satisfy
Phase 0 of the MRC Framework of Complex Interven-
tions, by documenting a theoretical basis to this study.
This will include:
(1) A scoping review to determine what is known from
published evidence about the social and practical needs
of adults living with advanced life limiting illness. (2) A
systematic review of community-led practical and/or so-
cial support interventions for adults living at home with
palliative and end of life care needs. (3) A small number
of interviews conducted with: (a) community dwelling
adults living with advanced life-limiting illness in Limer-
ick (n ≈ 6–8); (b) carers of community dwelling adults
living with advanced life-limiting illness in Limerick (n ≈
6–8); and (c) two focus groups with the primary care
team/Hospice at Home teams to determine the most
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Fig. 1 Overview of Phase 0-1 of the INSPIRE Study
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Fig. 2 Overview of Phase 2 of the INSPIRE Study
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important practical and social concerns for people living
with advanced life limiting illness, the needs of carers,
the assessment tools in use and the problems faced by
staff.
The results from this work will inform the final model
of intervention for the trial.
Phase I – Moldelling: Identify components of required
intervention and the underlying mechanisms, exploring
how the intervention might work in practice
The intervention requires a number of components to
be in place prior to commencment, including the re-
cruitment and training of at least 10 Compassionate
Communities Volunteers to deliver the intervention and
the development of associated procedures to operation-
alise the intervention (e.g. forms and procedures for
handling money/medication etc.). A mechanism of vol-
unteer support must also be developed. This phase in-
cludes the design, implementation and evaluation of a
brief training programme designed to enable volunteers
to fulfil their role, build confidence in communication
and other skills associated with the Good Neighbour
Partnership and potentially reduce death anxiety and in-
crease death self-efficacy.
A brief screening tool for healthcare staff will be se-
lected, or, if necessary, developed and tested, based on
the findings from Phase 0; this will be used in Phase II
to screen people in the community for their eligibility to
enter the trial. A tool to explore unmet social/practical
needs and social networks of adults living at home with
advanced life limiting illness and/or their carers, will also
be sourced, or if necessary developed.
Briefing sessions regarding the study will be held with
all primary care/home care teams in the City and
County through existing mechanisms of communication
with these groups.
The intervention and associated data collection tools
will be piloted with three community dwelling adults liv-
ing with life-limiting illness to determine feasibility prior
to the trial commencing (Fig. 1).
Phase II – exploratory delayed intervention randomised
controlled trial
Based on the outcome of Phases 0 and I, an exploratory
delayed intervention randomised controlled trial (RCT)
will be undertaken to assess the overall effectiveness of
the GNP. Ethically, a delayed intervention is considered
appropriate since it is not known at this stage, whether
or not the intervention is effective. People in the inter-
vention arm will receive the intervention immediately
following screening, whilst those in the delayed interven-
tion/control group will receive their usual care, and can
then elect to receive the intervention eight weeks after
screening. The RCT will be conducted with reference to
the CONSORT statement [22].
Randomisation
Randomisation will be conducted independently (and
after the baseline interview) by a statistician, using the
minimisation method [23]. This method will yield an
equal balance between groups by level of assessed social
and/or practical need and social network. This method
ensures a balanced distribution of potentially prognostic
factors, even in small trials [24]. The control group will
be monitored for contamination by the intervention at
the eight week interview where a question will be in-
cluded asking participants in the control group if they
have had contact with anyone who have received or
volunteered as part of the intervention.
Recruitment, consent and baseline interviews
Public Health Nurses (PHNs) and the Hospice at Home
Team staff will identify all patients/carers on their case-
load considered to be living at home, in their last year of
life with potential unmet social/practical needs who
meet the eligibility criteria for the study. During their
next routine interaction, staff will advise the person and/
or their main carer verbally, and in writing, about the re-
search and how the process of randomisation works.
They will then seek their voluntary informed consent for
their details to be provided to the Principal Investigator
(PI) (KMcL). The PI will visit the person within one
week to invite them to participate in the trial and to ob-
tain their written informed consent to do so. Subject to
consent, they will complete the baseline assessment of
social and practical need and social network with the PI,
together with a battery of research measures (see below),
after which they will be randomly assigned to either the
control or the intervention group.
Sample size
It is anticipated that up to 80 people will be recruited to
the INSPIRE trial. The trial is intended as a pilot, to test
procedures for acceptability, estimate the likely rates of
recruitment and retention of the participants, and per-
mit calculation of appropriate sample sizes based on the
primary outcome measure for future larger scale studies.
Given the exploratory nature of the trial, we estimate
that the proposed sample size of 80 is a realistic estimate
based on the nature of the intervention and the possible
size of the study population, as well as what is feasible
within the one year timeframe for the nature of the
Phase II element under the MRC Framework. A sample of
80 is also larger than that used in a similar study using a
delayed intervention RCT design to determine the effect-
iveness of a new palliative care service [25]. Furthermore,
as the precise choice of outcome measure depends on the
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findings from Phase 0 of the study, it is not possible at this
stage to conduct a power analysis. However, when we have
identified the primary outcome measure, we will be in a
better position to estimate sample size based on the ex-
pected difference on the outcome measure between the
control and intervention group, from use of the measure
with a similar population. This study has three units of
analysis: (1) the person living with life limiting illness; (2)
the carer and (3) the volunteers.
Inclusion criteria
Community dwelling adults (over 18 years) living with a
life-limiting illness in Limerick, considered by a member
of the primary care/hospice at home team to be in their
last year of life and/or their carer are eligible to partici-
pate in this study. Participants must have an advanced
diagnosis of one of the following conditions: Cancer, de-
mentia, frailty, neurological disease, heart disease, vascu-
lar disease, respiratory disease, kidney disease or liver
disease, and at least two of the general indicators of de-
teriorating health as outlined in the Supportive & Pallia-
tive Care Indicators Tool (SPICTTM) [26]. In addition,
the person must have: (a) unmet social and/or practical
needs; or (b) be socially isolated or (c) rely on just one
other person to meet their needs. Those who meet these
criteria, as outlined on the brief screening tool are eli-
gible for inclusion in the RCT.
Exclusion criteria
In the event that a person with a life limiting illness is
not able to engage in the study (as indicated by the
healthcare professional responsible for their care), due to
their condition or a cognitive impairment, data will not
be collected from them directly; instead, their carer will
be given the option to engage and complete measures
relevant to them.
Children and young people under the age of 18 years
are excluded from this study.
Services as usual (control)
People living in the community with advanced life limit-
ing illness receive a variety of services provided mainly
by the HSE Primary Care Team and, in the event of hav-
ing specialist palliative care needs, are offered multidis-
ciplinary specialist palliative care services via Milford
Care Centre’s Hospice at Home team. Depending on their
needs, they may also avail of acute hospital admission, out-
patient clinic or hospice admission. Non-Governmental
Organisations (e.g. the Carers Association and Alzheimer
Society Ireland) provide information on services and de-
liver support groups. In addition, they may be supported
by natural networks of carers, family members and friends
and the wider community. Participants in the control
group will complete measures at baseline, four weeks and
eight weeks as outlined below. At eight weeks, they will be
offered the opportunity to engage in the Good Neighbour
Partnership for an eight week cycle of intervention. This
will then be reviewed.
The intervention: the Good Neighbour Partnership (GNP)
The Good Neighbour Partnership can assist the person
affected by advanced illness, and their family, to find the
extra social and practical support required from within
their community by making links with those living
close-by who would like to help. The Partnership can
identify and mobilise additional help for activities such
as walking the dog, doing the shopping, collecting a pre-
scription, going to the library, filling a coal bucket, light-
ing the fire, mowing the lawn, making a snack, tidying
up or sitting with a person who needs a break. It does
not involve providing personal or physical care, heavy
lifting of people/objects nor does it provide help with
medical or financial matters.
At least 10 Compassionate Communities volunteers
will be recruited and trained to facilitate the Good
Neighbour Partnership over an 8-week intervention
period. The role of a Compassionate Community Vol-
unteer with the Good Neighbour Partnership is to
make the link between a person/family living with pal-
liative care needs at home, and those in their circle of
community who are able to offer support – to seek out
and enlist the “Good Neighbour” capacity within local
communities. All volunteers will be expected to
demonstrate:
 Maturity, common sense and the ability to be
discrete and sensitive
 A good understanding of ethical/confidentiality issues
 The ability to be confident and out-going, relate well
to others and communicate effectively
 A respectful and non-judgmental approach at all times
 A good sense of humour
 Good organisational skills and ability to complete
paperwork
 A good sense of personal boundaries and a clear
understanding of the purpose of the role
Volunteers will be nominated by a community organ-
isation, or by a person of good standing. They will have
Garda (Police) Clearance; references will be checked and
selection will be by interview with KMcL and JR. They
will be provided with initial training and ongoing sup-
port by Milford Care Centre. As part of that training,
they will be given a manual that has already been devel-
oped to help them understand their role, what is ex-
pected of them and what they can expect from Milford
Care Centre. Insurance will be provided by Milford Care
Centre and has already been agreed with the insurer.
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The volunteer recruitment and selection process has
already commenced and fourteen volunteers have been
selected for training.
The Good Neighbour Partnership Co-ordinator will
assign a Compassionate Communities Volunteer, taking
into account the profile of the person requiring support,
their age and gender, geographical location, personality
and the volunteer’s availability and experience. It is an-
ticipated that Compassionate Communities Volunteers
will meet with the person up to four times during the
8 week cycle.
The new intervention will be offered in addition to the
services as usual outlined above. This is designed to
complement existing services and not to duplicate or re-
place them. The intervention will be informed by Phase
0/I of this study, but an outline of what is expected, is
provided in Fig. 2.
Visit one
Within 72 h of initial screening and allocation to the
intervention, the assigned Compassionate Communities
Volunteer visits the person at a mutually agreed time, in
the person’s own home, to identify their social and prac-
tical needs and the type of support required. They identify
with the person, who in their circle of community they
would be happy to approach, to enable these needs to be
met. We refer to these people as “Good Neighbours”.
An agreement will be reached regarding a plan of ac-
tion. This may involve the person requiring support dir-
ectly approaching the identified Good Neighbours to
enable their needs to be met, perhaps agreeing on a for-
mula of words to “break the ice”. Alternatively, it may
also involve the Compassionate Communities Volunteer
directly asking the agreed Good Neighbours to engage
in the tasks identified. In the event that no-one has been
identified in the person’s circle of community, then an
agreement will be reached to approach community orga-
nisations and/or Milford Care Centre’s bank of Compas-
sionate Communities Good Neighbours to determine if
they are in a position to enable the need to be met.
Visit two/or phone call
Once agreement has been reached regarding who will
complete the specific tasks, the Compassionate Commu-
nities Volunteer will report back to the person requiring
support, to update them as to who will do what, and
when. It is anticipated that this visit will take 20 min
and in some cases, a phone call may suffice. Depending
on the situation, it may be necessary for the Compas-
sionate Communities Volunteer to accompany the Good
Neighbours completing the task on their first visit, to
introduce them to the person who requires support. As-
sistance is provided without an expectation or implica-
tion of payment or other reward or benefit.
Visit three
Four weeks after the first visit, the Compassionate Com-
munities Volunteer will visit again, to determine if the
new arrangements/systems are working well, or if there
needs to be any changes to the plan/modified supports.
A mid-way interview will also be conducted two days
later by the PI. It is anticipated that this visit will take
30 minutes.
Visit four
Eight weeks after the first visit, the Compassionate Com-
munities Volunteer will visit again to evaluate the
process and determine if any additional support is re-
quired. A second eight week cyle of intervention may be
offered at this point depending on needs identified, and
this may be included as a follow up of the main study. It
is anticipated that this visit will take 30 minutes and a final
interview will be conducted two days later by the PI.
All visits will be agreed in advance and will be made
by appointment only. Compassionate
Communities Volunteers will be asked to keep a rec-
ord of their visits on a Good Neighbour Partnership Re-
port Form. This will be used to record information on
date and duration of visits, and types of activity under-
taken. Volunteers will be asked to remind the “Good
Neighbours” to keep a note of their visits on a separate
similar form. At the end of the 8-week cycle, these forms
will be returned to the Good Neighbour Partnership
Co-ordinator.
Where a participant leaves their home during the eight
week cycle (e.g., admitted to hospital) they will continue
to receive the intervention and participate in the study if
they are willing to do so.
The trial: data collection and outcome measures
Data will be collected for both groups on a face-to-face
basis in the person’s home. This will include standar-
dised questionnaires used to record demographic infor-
mation, relevant clinical data, social and practical needs
and the nature and extent of social networks. Relevant
outcome measures will be identified following Phase 0,
but some of the kinds of measures that are likely to be
used are outlined below.
People living with illness may be asked to complete
(with help) measures such as: (i) The FACIT-PAL-14
[27]; (ii) The UCLA 3-item loneliness scale [28]; (iii) The
eight-item modified Medical Outcomes Study Social
Support Survey (mMOS-SS) [29]; (iv) Items regarding
community and generalised trust, cohesion and social
inclusion from Lewis’s Social Capital Questionnaire [30]
and a measure of social and/or practical need and social
network. Carers engaged in the study may complete
measures such as: (i) the 11-item Duke Social Support
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Index [31]; and (ii) the American Medical Association
Carer Self-Support Survey [32].
Measures will be completed at T0 (baseline), T1
(4 weeks) and T2 (8 weeks) as recommended by Greene
[33]. The place of care over time, use of paid and unpaid
resources and unplanned health service utilisation will
also be recorded at each time period. The researcher will
read out the questionnaires to the person and show po-
tential responses on large print, laminated A4 flash cards
to aid those with any visual impairment.
Process evaluation
A ‘mini’ process evaluation will also be nested within the
INSPIRE trial and conducted at the end of the study,
when a small, but diverse, number of patients, carer and
volunteers will be invited to take part in a one-to-one
interview to explore their experience and views of the
new intervention and the process of its implementation.
In addition, the time taken to obtain informed consent
and collect data, exclusions, recruitment and drop-out
rates (patients, their family and volunteers) and missing
data will be recorded and reported throughout the
course of the RCT.
Ethical approval
An application for ethical approval was submitted to the
Mid-West University Hospitals Scientific Research Eth-
ics Committee in September 2014 and was approved in
November 2014.
Data analysis
Phase 0
Qualitative data from interviews and focus groups will
be transcribed, anonymised and entered into MAXQDA
for standard thematic analysis. Other qualitative ana-
lytical techniques (e.g., grounded theory) will also be
considered.
Phase I: implementation and pilot testing of compassionate
communities volunteer training
Descriptive and inferential statistics with specific pre-
and post- training comparisons and utilising appropriate
tests to assess any change over time in death anxiety and
confidence in communication.
Phase 2: exploratory (parallel group) RCT
Trial data will be cleaned, checked for coding errors and
entered into SPSS for analysis. Differences between the
control and intervention groups at baseline will be ex-
amined. Given that studies, such as that proposed here,
can be subject to attrition and missing data [33], we will
endeavour to utilise the recommendation from MORE-
care [34] to manage these issues should they arise in this
study (e.g. examining patterns of missing data and
utilising a taxonomy of attrition). The primary endpoint
will be change in unmet social and/or practical needs in
the intention-to-treat sample. Secondary efficacy end-
points have also been described. Other end-points in-
clude death and the person requesting withdrawal from
the study.
It is likely that an analysis of covariance (ANCOVA)
for the primary endpoint and for secondary endpoints
will be conducted, supplemented by a repeated measures
analysis. However, at this stage, given the lack of cer-
tainty around the total sample size (and its distribution),
it is perhaps appropriate to highlight that the method of
analysis will involve fitting between group, repeated
measures models with two levels of treatment variable
(intervention group, control group) and three time
points (T0, T1, T2) to the primary and secondary out-
come measures. Model assumptions will be checked and
where there is evidence of non-normal distribution, out-
comes will be transformed, for example by dichotomis-
ing or categorising data. Auxiliary analyses will assess
the interaction of potential modifiers (for e.g., age, sex,
size of social network at baseline) with treatment in the
models.
Phase 2: experience and impact of engaging as a volunteer
Descriptive and inferential statistics with specific pre-
and post–intervention comparisons using appropriate
statistical tests (sample size dependent) to determine any
changes in the community volunteers with regard to
death self-efficacy (as measured by The Death Self-
Efficacy Scale [35], fear of death (as measured by The
Revised Collett-Lester Fear of Death and Dying Scale
[36] and self-reported confidence with the eleven skills
considered important for their role.
Process evaluation
All qualitative data will be transcribed, anonymised and
entered into MAXQDA in preparation for analysis. A
number of qualitative analytical techniques will be con-
sidered, such as grounded theory or Framework analysis.
Discussion
It is anticipated that the findings from the various ele-
ments of the INSPIRE study will represent an invaluable
addition to international literature and provide import-
ant insights into the effectiveness, efficacy, utility and ac-
ceptability of a unique model of social and practical care
for people with life-limiting illness. This will help to in-
form the development of similar models in other juris-
dictions and potentially provide the basis for a larger
full-scale RCT into the future. If the INSPIRE trial
shows that volunteer-led models of social care and prac-
tical support are effective, it could provide evidence to
show that a relatively low cost intervention can be
McLoughlin et al. BMC Palliative Care  (2015) 14:65 Page 9 of 10
offered routinely with support from specialist palliative
care and primary healthcare providers.
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